Emergence of Salmonella Genomic Island 1 Variant SGI1-W in a Clinical Isolate of Providencia stuartii from Egypt

Antimicrob Agents Chemother. 2018 Dec 21;63(1):e01793-18. doi: 10.1128/AAC.01793-18. Print 2019 Jan.

Authors

Ahmed M Soliman^{1

2}, Toshi Shimamoto¹, Hirofumi Nariya¹, Tadashi Shimamoto³

Affiliations

¹ Laboratory of Food Microbiology and Hygiene, Graduate School of Biosphere Science, Hiroshima University, Higashi-Hiroshima, Japan.
² Department of Microbiology and Immunology, Faculty of Pharmacy, Kafrelsheikh University, Kafr El-Sheikh, Egypt.
³ Laboratory of Food Microbiology and Hygiene, Graduate School of Biosphere Science, Hiroshima University, Higashi-Hiroshima, Japan tadashis@hiroshima-u.ac.jp.

No abstract available

Keywords: Egypt; Providencia stuartii; SGI1-W; Salmonella genomic island 1; trmE.

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Anti-Bacterial Agents / pharmacology
Cephalosporins / pharmacology
Chloramphenicol / pharmacology
Chromosome Mapping
Chromosomes, Bacterial / chemistry*
Ciprofloxacin / pharmacology
Drug Resistance, Multiple, Bacterial / genetics*
Enterobacteriaceae Infections / diagnosis
Enterobacteriaceae Infections / drug therapy
Enterobacteriaceae Infections / microbiology*
Gene Transfer, Horizontal*
Genomic Islands*
Humans
Integrons
Male
Morganella morganii / genetics
Proteus Infections / genetics
Providencia / drug effects
Providencia / genetics*
Providencia / growth & development
Providencia / isolation & purification
Salmonella typhimurium / genetics
Thiamphenicol / analogs & derivatives
Thiamphenicol / pharmacology

Substances

Anti-Bacterial Agents
Cephalosporins
Ciprofloxacin
Chloramphenicol
florfenicol
Thiamphenicol

Supplementary concepts

Providencia stuartii